<DOC>
	<DOCNO>NCT02303847</DOCNO>
	<brief_summary>This project pilot study evaluate analgesic opioid-sparing effect ketamine ultra-low dose oral formulation novel intervention treatment chronic non-cancer pain opioid-tolerant patient primary care outpatient setting .</brief_summary>
	<brief_title>Ultra-low Dose Oral Ketamine Chronic Pain Primary Care Setting</brief_title>
	<detailed_description>Chronic pain major national public health issue , affect 100 million adult United States . Opioid pain medication commonly use treatment chronic pain , use fraught consequence include increase prevalence misuse , abuse , overdose death , side effect lead reduce quality life . An effective safe medication would improve control chronic pain reduce reliance opioid medication would valuable patient , medical provider society large . Ketamine , commonly use intravenous anesthetic agent , show analgesic opioid-sparing effect peri-operative period palliative care set . Based promising preliminary data open-label treatment trial , project pilot study evaluate analgesic opioid-sparing effect ketamine ultra-low dose oral formulation novel intervention treatment chronic non-cancer pain primary care outpatient setting . The design propose study randomize control two week parallel-group trial , 32 patient receive either active treatment placebo twice daily .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Age 18 year old Routine use opioid medication noncancer pain six month A current average daily dose great equal 20 mg morphine equivalent Current prescription asneeded opioid suitable downward titration study period Ability provide inform consent Ability adhere study protocol Uncontrolled hypertension , cardiac arrhythmia know cardiac disease , elevate intracranial pressure , severe glaucoma , schizophrenia , diagnose substance use disorder , unstable medical psychiatric illness pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>